每周股票复盘：振德医疗（603301）选举新职工代表董事及多项议案待审

Core Viewpoint - Zhendemedical (603301) has seen a stock price increase of 0.91% to 22.19 yuan as of August 1, 2025, with a total market capitalization of 5.913 billion yuan [1] Company Announcements - The company announced the election of Zhang Xiantao as the employee representative director for the fourth board of directors, following the expiration of the third board's term [1][4] - The first extraordinary general meeting of shareholders in 2025 will be held on August 11, 2025, to review multiple proposals, including the salary scheme for the fourth board of directors and the cancellation of the supervisory board [2][3] - The company plans to cancel the supervisory board, transferring its powers to the audit committee of the board of directors [2][4] - The registered capital will be reduced from 266,451,202 yuan to 265,835,535 yuan [2][4] - The business scope will be expanded to include the sale of sanitary insecticides [2][4] - The company will repurchase 615,667 shares from the first employee stock ownership plan at a price of 25.16 yuan per share, changing the purpose of the repurchased shares from "implementation of employee stock ownership plan" to "cancellation and reduction of registered capital" [3][4]